Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Parathyroid Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-Small-Cell Lung 1NSCLC 1Gastrointestinal Neoplasms 1Esthesioneuroblastoma, Olfactory 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Adenocarcinoma, Follicular 1Adenocarcinoma of Lung 1

Interventions

icotinib 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Non-Small-Cell Lung × Gefitinib × Clear all
NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

The First Affiliated Hospital of Soochow University

Phase NA Unknown
66 enrolled
Thoracic

Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡